Results 131 to 140 of about 21,238,241 (185)

CYFRA21-1 as a Tumor Marker in Patients with Malignant Head and Neck Tumor.

Practica Oto-Rhino-Laryngologica, 1996
OGAWA, Teruhiro, NISHIZAKI, Kazunori, AKAGI, Hirohumi, TSURUSAKO, Hirokazu, NISHIOKA, Keiko, ODA, Kazunari, KIMURA, Nobuhiko   +6 more
openaire   +2 more sources

The combination assay of CYFRA21-1/ProGRP in Primary Lung Cancer.

Japan Journal of Molecular Tumor Marker Research, 1999
openaire   +1 more source

Serum tumor marker CYFRA21-1 in patients with malignant pleural mesothelioma

Japan Journal of Molecular Tumor Marker Research, 2002
N., M., N., T., Y., H., Y., S., I., S., U., A., T., A., M., M., H., T.   +8 more
openaire   +1 more source

Effect of gefitinib on serum EGFR and CYFRA21-1 in patients with advanced non-small cell lung cancer. [PDF]

Oncol Lett, 2019
Ren H, Hu Y, Xie T, Jin C, Hu Y, Yang B.
europepmc   +1 more source

lk27 [PDF]

1, 1
core  

Exosomal 3'tiRNA-PheGAA and interleukin-6 as novel biomarkers for non-invasive detection of NSCLC. [PDF]

Discov Oncol
Yuan N, Zhang Q, Shi J, Cheng W, Zhao B, Zhang Z.   +5 more
europepmc   +1 more source

Safety and Clinical Outcomes of Kanglaite Injection in Combination with Toripalimab and Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Analysis. [PDF]

Cancer Manag Res
Zhang R, Feng Z, Pan X, Lin Q, Huang C, Wei X.   +5 more
europepmc   +1 more source

Diagnostic value of serum biomarkers for identifying computed tomography abnormalities in male miners. [PDF]

Sci Rep
Huang Q, Lai L, Diao J, Chen L, Fang B.
europepmc   +1 more source

Performance validation and clinical concordance of a novel fully automated immunoassay system for five tumor markers: A comparative study with an international reference platform. [PDF]

Pract Lab Med
Wang R, Liu J, Cao T, Qiao X, Deng X, Xiong T, Yang Y, Zhang J, Li M, Liang W.   +9 more
europepmc   +1 more source

Prognostic analysis and development of a prognostic model for EML4-ALK-positive lung cancer patients treated with ALK-TKIs. [PDF]

Front Med (Lausanne)
Liu R, Su C, Su H, Wang L.
europepmc   +1 more source